Endovantage gains US FDA 510(k) clearance for Surgicalpreview
David Frakes, a Fulton Schools associate professor of biomedical engineering, is one of the founders of the Endovantage venture. The company has gotten approval from the U.S. Food and Drug Administration for a new tool for preoperative planning. Called Surgical Preview, it is designed to enable physicians to use 3D modeling and visualization of surgical placement of endovascular devices in patients. The goal is to reduce the risks to patients and improve outcomes.